Skip to main content

Medical and Administrative Data on Health Insurance

CNAM Uses

  • Chapter
  • First Online:
Healthcare and Artificial Intelligence
  • 979 Accesses

Abstract

The accumulation of data through the digitalization of processes in the health sector as in other fields has become a challenge for all actors in the sector including health insurance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 37.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 37.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    See chapter “Artificial Intelligence and Tomorrow's Health” in Health Insurance Annual Proposal Reports: www.ameli.fr/l-assurance-maladie/statistiques-et-publications/rapports-et-periodicreports/reports-charges-products-of-medical-insurance/index.php.

  2. 2.

    Work carried out by Caisse nationale de l’Assurance maladie des travailleurs salariés (CNAMTS) led to suspension of the use of the antidiabetic pioglitazone in France on June 9, 2011 and its withdrawal from the French market by the Agence du medicament (Afssaps) of pioglitazone (Actos and Competact). Neumann A., Weill A., Ricordeau P., Fagot J.-P., Alla F., Allemand H., “Pioglitazone and risk of bladder cancer among diabetic patients in France: A population-based cohort study,” Diabetologia, July 2012, 55(7), 1953–1962.

  3. 3.

    Tuppin P., Rudant J., Constantinou P., Gastaldi-Ménager C., Rachas A., de Roquefeuil L., Maura G., Caillol H., Tajahmady A., Coste J., Gissot C., Weill A., Fagot-Campagna A., Direction de la stratégie des études et des statistiques (DSES), Caisse nationale d’Assurance maladie des travailleurs salariés, “L’utilité d’une base médico-administrative nationale pour guider la décision publique: du système national d’information interrégimes de l’Assurance maladie (SNIIRAM) vers le système national des données de santé (SNDS) en France,” October 2017, 65, supplement 4, S149–S167.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claude Gissot .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gissot, C. (2020). Medical and Administrative Data on Health Insurance. In: Nordlinger, B., Villani, C., Rus, D. (eds) Healthcare and Artificial Intelligence. Springer, Cham. https://doi.org/10.1007/978-3-030-32161-1_6

Download citation

Publish with us

Policies and ethics